T-LYMPHOCYTIC LEUKEMIA, ACUTE

Clinical trials for T-LYMPHOCYTIC LEUKEMIA, ACUTE explained in plain language.

Never miss a new study

Get alerted when new T-LYMPHOCYTIC LEUKEMIA, ACUTE trials appear

Sign up with your email to follow new studies for T-LYMPHOCYTIC LEUKEMIA, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat leukemia: drug combo trial targets High-Risk cases

Disease control Ongoing

This trial is testing whether adding the drug daratumumab to standard chemotherapy can help more adults with very high-risk T-cell acute lymphoblastic leukemia (T-ALL) achieve deep remission. The study will enroll 31 adults aged 18-65 with specific high-risk features. Researchers…

Matched conditions: T-LYMPHOCYTIC LEUKEMIA, ACUTE

Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

T-LYMPHOCYTIC LEUKEMIA, ACUTE

Get alerted when new T-LYMPHOCYTIC LEUKEMIA, ACUTE trials appear

New hope for Tough-to-Treat leukemia: drug combo trial targets High-Risk cases